Verdicts genuinely change. Free email alert the moment THQ's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
abrdn Healthcare Opportunities Fund
110 holdings
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 127% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT 40.06% of portfolio weight is in non-compliant holdings, over the 5% threshold.
110 holdings, 74 matched (74% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.
0.93% of this portfolio’s income is non-permissible — weighted across holdings, computed over 66% of portfolio weight (63 of 110 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
42.5% compliant 0.0% questionable 31.4% non-compliant 26.1% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 6.07% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| VeraDermics Inc | UNSCREENED | 5.27% | no in-house ratios for this holding |
| ABT Abbott Laboratories | COMPLIANT | 4.77% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| MRK Merck & Co Inc | COMPLIANT | 4.41% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| MDT Medtronic PLC | COMPLIANT | 4.26% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 4.19% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| VERADERMICS, INC. | UNSCREENED | 4.07% | no in-house ratios for this holding |
| ISRG Intuitive Surgical Inc | COMPLIANT | 3.39% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| CVS CVS Health Corp | NON_COMPLIANT | 3.30% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| DHR Danaher Corp | COMPLIANT | 3.22% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| Oruka Therapeutics Inc | UNSCREENED | 2.89% | no in-house ratios for this holding |
| uniQure NV | UNSCREENED | 2.77% | no in-house ratios for this holding |
| HUM Humana Inc | NON_COMPLIANT | 2.75% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| ELV Elevance Health Inc | NON_COMPLIANT | 2.56% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| BioCryst Pharmaceuticals Inc | UNSCREENED | 2.53% | no in-house ratios for this holding |
| ABBV AbbVie Inc | COMPLIANT | 2.47% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| BSX Boston Scientific Corp | COMPLIANT | 2.40% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| Sarepta Therapeutics Inc | UNSCREENED | 2.01% | no in-house ratios for this holding |
| NEO NeoGenomics Inc | COMPLIANT | 1.89% | AAOIFI19.5% Usmani33.2% Dow Jones Islamic30.5% S&P Shariah27.4% MSCI Islamic32.7% MSCI Islamic M-Series27.4% FTSE Shariah27.7% |
| PODD Insulet Corp | COMPLIANT | 1.88% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| State Street Global Advisors | UNSCREENED | 1.86% | no in-house ratios for this holding |
| Praxis Precision Medicines Inc | UNSCREENED | 1.77% | no in-house ratios for this holding |
| SPRY ARS Pharmaceuticals Inc | NON_COMPLIANT | 1.75% | AAOIFI17.3% Usmani38.7% Dow Jones Islamic8.7% S&P Shariah9.8% MSCI Islamic38.7% MSCI Islamic M-Series9.8% FTSE Shariah38.7% |
| Abivax SA | UNSCREENED | 1.68% | no in-house ratios for this holding |
| ALHC Alignment Healthcare Inc | COMPLIANT | 1.66% | AAOIFI11.6% Usmani25.3% Dow Jones Islamic10.0% S&P Shariah12.5% MSCI Islamic25.3% MSCI Islamic M-Series12.5% FTSE Shariah25.3% |
| OHI Omega Healthcare Investors Inc | NON_COMPLIANT | 1.61% | AAOIFI30.5% Usmani42.9% Dow Jones Islamic37.6% S&P Shariah43.5% MSCI Islamic42.9% MSCI Islamic M-Series43.5% FTSE Shariah42.9% |
| WELL Welltower Inc | COMPLIANT | 1.59% | AAOIFI10.6% Usmani26.7% Dow Jones Islamic15.6% S&P Shariah19.1% MSCI Islamic26.7% MSCI Islamic M-Series19.1% FTSE Shariah26.7% |
| VCEL Vericel Corp | COMPLIANT | 1.59% | AAOIFI4.0% Usmani18.5% Dow Jones Islamic4.4% S&P Shariah4.4% MSCI Islamic18.4% MSCI Islamic M-Series4.4% FTSE Shariah0.0% |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 1.55% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| MOH Molina Healthcare Inc | NON_COMPLIANT | 1.45% | AAOIFI36.0% Usmani24.7% Dow Jones Islamic29.7% S&P Shariah24.7% MSCI Islamic23.6% MSCI Islamic M-Series24.7% FTSE Shariah23.6% |
| WGS GeneDx Holdings Corp | COMPLIANT | 1.43% | AAOIFI4.7% Usmani20.1% Dow Jones Islamic3.9% S&P Shariah5.5% MSCI Islamic20.1% MSCI Islamic M-Series5.5% FTSE Shariah20.1% |
| ACHC Acadia Healthcare Co Inc | NON_COMPLIANT | 1.26% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| DOC Healthpeak Properties Inc | NON_COMPLIANT | 1.26% | AAOIFI67.5% Usmani46.3% Dow Jones Islamic80.6% S&P Shariah86.7% MSCI Islamic46.3% MSCI Islamic M-Series86.7% FTSE Shariah46.3% |
| ABT ABBOTT LABORATORIES | COMPLIANT | 1.24% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| CRL Charles River Laboratories International Inc | COMPLIANT | 1.22% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VTR Ventas Inc | COMPLIANT | 1.19% | AAOIFI28.0% Usmani42.8% Dow Jones Islamic38.5% S&P Shariah45.5% MSCI Islamic42.8% MSCI Islamic M-Series45.5% FTSE Shariah42.8% |
| OCSAW Oculis Holding AG | NON_COMPLIANT | 1.16% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.0% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ZTS Zoetis Inc | NON_COMPLIANT | 1.14% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| SBRA Sabra Health Care REIT Inc | NON_COMPLIANT | 1.14% | AAOIFI49.4% Usmani47.6% Dow Jones Islamic61.2% S&P Shariah69.2% MSCI Islamic47.6% MSCI Islamic M-Series69.2% FTSE Shariah47.6% |
| Biodesix Inc | UNSCREENED | 1.08% | no in-house ratios for this holding |
| SYK Stryker Corp | COMPLIANT | 1.05% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| CI CIGNA GROUP/THE | NON_COMPLIANT | 1.05% | AAOIFI42.7% Usmani20.3% Dow Jones Islamic40.5% S&P Shariah38.8% MSCI Islamic20.3% MSCI Islamic M-Series38.8% FTSE Shariah20.3% |
| ICLR ICON PLC | COMPLIANT | 1.05% | AAOIFI17.7% Usmani13.7% Dow Jones Islamic16.2% S&P Shariah13.0% MSCI Islamic13.7% MSCI Islamic M-Series13.0% FTSE Shariah12.9% |
| JNJ JOHNSON & JOHNSON | COMPLIANT | 0.98% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| PFE PFIZER INC | NON_COMPLIANT | 0.96% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| GEHC GE HealthCare Technologies Inc | NON_COMPLIANT | 0.94% | AAOIFI34.9% Usmani28.5% Dow Jones Islamic30.2% S&P Shariah30.1% MSCI Islamic28.4% MSCI Islamic M-Series30.1% FTSE Shariah27.3% |
| WAT Waters Corp | COMPLIANT | 0.93% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| MCK McKesson Corp | COMPLIANT | 0.91% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| MYGN Myriad Genetics Inc | NON_COMPLIANT | 0.91% | AAOIFI69.0% Usmani32.9% Dow Jones Islamic25.9% S&P Shariah18.2% MSCI Islamic32.9% MSCI Islamic M-Series18.2% FTSE Shariah18.9% |
| Disc Medicine Inc | UNSCREENED | 0.89% | no in-house ratios for this holding |
| IQV IQVIA Holdings Inc | NON_COMPLIANT | 0.86% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| RGEN Repligen Corp | COMPLIANT | 0.80% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| TMO THERMO FISHER SCIENTIFIC | COMPLIANT | 0.78% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| RCUS Arcus Biosciences Inc | COMPLIANT | 0.78% | AAOIFI3.0% Usmani12.3% Dow Jones Islamic5.9% S&P Shariah6.5% MSCI Islamic12.3% MSCI Islamic M-Series6.5% FTSE Shariah10.9% |
| INSP Inspire Medical Systems Inc | COMPLIANT | 0.76% | AAOIFI1.6% Usmani3.1% Dow Jones Islamic0.8% S&P Shariah0.7% MSCI Islamic3.1% MSCI Islamic M-Series0.7% FTSE Shariah0.0% |
| BDX Becton Dickinson & Co | NON_COMPLIANT | 0.73% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| Mineralys Therapeutics Inc | UNSCREENED | 0.72% | no in-house ratios for this holding |
| THIRD ARC BIO, INC | UNSCREENED | 0.69% | no in-house ratios for this holding |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 0.69% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| ZBH ZIMMER BIOMET HOLDINGS | NON_COMPLIANT | 0.67% | AAOIFI40.7% Usmani32.8% Dow Jones Islamic39.1% S&P Shariah36.3% MSCI Islamic32.8% MSCI Islamic M-Series36.3% FTSE Shariah32.8% |
| LTC LTC Properties Inc | NON_COMPLIANT | 0.65% | AAOIFI35.4% Usmani35.7% Dow Jones Islamic47.6% S&P Shariah52.3% MSCI Islamic35.7% MSCI Islamic M-Series52.3% FTSE Shariah35.7% |
| AZN ASTRAZENECA PLC | COMPLIANT | 0.64% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ELV ELEVANCE HEALTH INC | NON_COMPLIANT | 0.64% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| CI CIGNA GROUP/THE | NON_COMPLIANT | 0.63% | AAOIFI42.7% Usmani20.3% Dow Jones Islamic40.5% S&P Shariah38.8% MSCI Islamic20.3% MSCI Islamic M-Series38.8% FTSE Shariah20.3% |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 0.58% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| GLYCOMINE, INC. | UNSCREENED | 0.54% | no in-house ratios for this holding |
| CRYSTALYS THERAPEUTICS SER A | UNSCREENED | 0.51% | no in-house ratios for this holding |
| Lucid Diagnostics Inc | UNSCREENED | 0.50% | no in-house ratios for this holding |
| MRK MERCK & CO INC | COMPLIANT | 0.47% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| Perceptive Capital Solutions Corp | UNSCREENED | 0.47% | no in-house ratios for this holding |
| CDNA CareDx Inc | COMPLIANT | 0.44% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ENDEAVOR BIOMEDICINES, INC. | UNSCREENED | 0.42% | no in-house ratios for this holding |
| SYK STRYKER CORP | COMPLIANT | 0.42% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| SEISMIC THERAPEUTICS, INC. | UNSCREENED | 0.40% | no in-house ratios for this holding |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 0.40% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| ELV ELEVANCE HEALTH INC | NON_COMPLIANT | 0.36% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| PFE PFIZER INC | NON_COMPLIANT | 0.36% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| TNDM Tandem Diabetes Care Inc | NON_COMPLIANT | 0.35% | AAOIFI53.4% Usmani64.0% Dow Jones Islamic49.0% S&P Shariah43.9% MSCI Islamic64.0% MSCI Islamic M-Series43.9% FTSE Shariah52.2% |
| SpyGlass Pharma Inc | UNSCREENED | 0.35% | no in-house ratios for this holding |
| DXCM Dexcom Inc | COMPLIANT | 0.35% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| ALKS Alkermes PLC | COMPLIANT | 0.34% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| DHC Diversified Healthcare Trust | NON_COMPLIANT | 0.33% | AAOIFI134.3% Usmani57.6% Dow Jones Islamic211.6% S&P Shariah249.7% MSCI Islamic57.6% MSCI Islamic M-Series249.7% FTSE Shariah57.6% |
| MOBI Mobia Medical Inc | NON_COMPLIANT | 0.32% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.6% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ABBV ABBVIE INC | COMPLIANT | 0.32% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| LLY Eli Lilly & Co | COMPLIANT | 0.32% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| SERA Sera Prognostics Inc | NON_COMPLIANT | 0.30% | AAOIFI3.7% Usmani3.5% Dow Jones Islamic2.8% S&P Shariah2.3% MSCI Islamic3.5% MSCI Islamic M-Series2.3% FTSE Shariah0.0% |
| ELV ELEVANCE HEALTH INC | NON_COMPLIANT | 0.24% | AAOIFI35.1% Usmani24.6% Dow Jones Islamic37.4% S&P Shariah33.5% MSCI Islamic24.6% MSCI Islamic M-Series33.5% FTSE Shariah24.6% |
| THC Tenet Healthcare Corp | NON_COMPLIANT | 0.24% | AAOIFI63.5% Usmani43.2% Dow Jones Islamic83.2% S&P Shariah95.3% MSCI Islamic43.2% MSCI Islamic M-Series95.3% FTSE Shariah43.2% |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 0.24% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| Seaport Therapeutics Inc | UNSCREENED | 0.23% | no in-house ratios for this holding |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.23% | no in-house ratios for this holding |
| ATALANTA THERAPEUTICS | UNSCREENED | 0.21% | no in-house ratios for this holding |
| Revolution Medicines Inc | UNSCREENED | 0.20% | no in-house ratios for this holding |
| HR Healthcare Realty Trust Inc | NON_COMPLIANT | 0.19% | AAOIFI63.6% Usmani46.3% Dow Jones Islamic71.4% S&P Shariah74.8% MSCI Islamic46.3% MSCI Islamic M-Series74.8% FTSE Shariah46.3% |
| CI CIGNA GROUP/THE | NON_COMPLIANT | 0.18% | AAOIFI42.7% Usmani20.3% Dow Jones Islamic40.5% S&P Shariah38.8% MSCI Islamic20.3% MSCI Islamic M-Series38.8% FTSE Shariah20.3% |
| DH EUROPE FINANCE II | UNSCREENED | 0.17% | no in-house ratios for this holding |
| ABCURO, INC. | UNSCREENED | 0.15% | no in-house ratios for this holding |
| Odyssey Therapeutics Inc | UNSCREENED | 0.11% | no in-house ratios for this holding |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 0.11% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| ENDEAVOR BIOMEDICINES INC. | UNSCREENED | 0.11% | no in-house ratios for this holding |
| NSPR InspireMD Inc | NON_COMPLIANT | 0.11% | AAOIFI4.9% Usmani4.4% Dow Jones Islamic2.8% S&P Shariah2.9% MSCI Islamic4.4% MSCI Islamic M-Series2.9% FTSE Shariah0.0% |
| ABCURO INC. | UNSCREENED | 0.10% | no in-house ratios for this holding |
| ENGRAIL THERAPEUTICS INC. SERI | UNSCREENED | 0.10% | no in-house ratios for this holding |
| Avalyn Pharma Inc | UNSCREENED | 0.08% | no in-house ratios for this holding |
| Hemab Therapeutics Holdings Inc | UNSCREENED | 0.07% | no in-house ratios for this holding |
| NHI National Health Investors Inc | NON_COMPLIANT | 0.05% | AAOIFI36.6% Usmani43.0% Dow Jones Islamic37.3% S&P Shariah41.8% MSCI Islamic43.0% MSCI Islamic M-Series41.8% FTSE Shariah43.0% |
| OCULIS HOLDINGS AG | UNSCREENED | 0.04% | no in-house ratios for this holding |
| Options Clearing Corp. | UNSCREENED | 0.02% | no in-house ratios for this holding |
| CONTRA FUSION PHARMACE | UNSCREENED | 0.00% | no in-house ratios for this holding |
| IO LIGHT HOLDINIGS, INC. | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 12 points of portfolio weight — 60.7% of it passes S&P Shariah, 48.6% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 59.3% ratios fail on 28.3% 39.8% not rated under AAOIFI
ratios pass on 49.8% ratios fail on 36.2% 41.4% not rated under Usmani
ratios pass on 59.8% ratios fail on 25.9% 41.7% not rated under Dow Jones Islamic
ratios pass on 60.7% ratios fail on 24.9% 41.8% not rated under S&P Shariah
ratios pass on 48.6% ratios fail on 40.6% 38.2% not rated under MSCI Islamic
ratios pass on 60.7% ratios fail on 25.0% 41.7% not rated under MSCI Islamic M-Series
ratios pass on 54.0% ratios fail on 33.6% 39.8% not rated under FTSE Shariah
59 of 110 listed holdings carry our own per-methodology verdicts (94% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 52 (86% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 6.07% |
| CVS CVS Health Corp | 3.30% |
| HUM Humana Inc | 2.75% |
| ELV Elevance Health Inc | 2.56% |
| SPRY ARS Pharmaceuticals Inc | 1.75% |
| OHI Omega Healthcare Investors Inc | 1.61% |
| BMY Bristol-Myers Squibb Co | 1.55% |
| MOH Molina Healthcare Inc | 1.45% |
| ACHC Acadia Healthcare Co Inc | 1.26% |
| DOC Healthpeak Properties Inc | 1.26% |
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
abrdn Healthcare Opportunities Fund (THQ) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A holding it cannot cover far enough is reported as unrated rather than counted as a pass.
| Holding | Weight | Verdict |
|---|---|---|
| UNHUnitedHealth Group Inc | 6.07% | Non-compliant |
| VeraDermics Incnot matched to a ticker | 5.27% | Not screened |
| ABTAbbott Laboratories | 4.77% | Compliant |
| MRKMerck & Co Inc | 4.41% | Compliant |
| MDTMedtronic PLC | 4.26% | Compliant |
| TMOThermo Fisher Scientific Inc | 4.19% | Compliant |
| VERADERMICS, INC.not matched to a ticker | 4.07% | Not screened |
| ISRGIntuitive Surgical Inc | 3.39% | Compliant |
| CVSCVS Health Corp | 3.30% | Non-compliant |
| DHRDanaher Corp | 3.22% | Compliant |
Top 10 of 110 holdings, 42.9% of the fund by weight. Every holding is screened, not only these.
The positions keeping this fund short of 100% compliant by weight.
Verdict history for THQ. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
Tracked since 2026-09-07.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 27.30 | BUY |
| Stochastic %K (14) | 2.75 | BUY |
| CCI (20) | -169.85 | BUY |
| Williams %R (14) | -97.25 | BUY |
| MACD (12,26,9) | -0.14 | SELL |
| ROC (10) | -8.89 | SELL |
| Momentum (10) | -1.71 | SELL |
| EMA (10) | 18.14 | SELL |
| SMA (10) | 18.24 | SELL |
| EMA (20) | 18.48 | SELL |
| SMA (20) | 18.59 | SELL |
| EMA (30) | 18.63 | SELL |
| SMA (30) | 18.91 | SELL |
| EMA (50) | 18.67 | SELL |
| SMA (50) | 18.93 | SELL |
| EMA (100) | 18.43 | SELL |
| SMA (100) | 18.45 | SELL |
| EMA (200) | 17.92 | SELL |
| SMA (200) | 17.91 | SELL |
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.